GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

NCT06390904 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Atypical Endometrial Hyperplasia
Progesterone Resistance
Obesity

Interventions

DRUG: GnRH antagonist
DRUG: Letrozole 2.5mg

Sponsor

Xiaojun Chen